Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity
Clinical trial NCT05076227 · COMPLETED
Trial details
- NCT number
- NCT05076227
- Sponsor
- Serge Thal
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-30
- Primary completion
- 2022-03-27
- Enrollment
- 1206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.